| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/27/1998 | US5712111 DNA encoding bradykinin B1 receptor |
| 01/27/1998 | US5712104 Screening test for cancer, aids/hiv, influenza |
| 01/27/1998 | US5712102 Method of screening compounds which inhibit P. gingivalis lipopolysaccharide from inhibiting the extravasation of leukocytes |
| 01/27/1998 | US5712101 Glycosylation of hemoglobin, quantification, reaction with epitopes for detection of diabetes |
| 01/27/1998 | US5712098 Hereditary hemochromatosis diagnostic markers and diagnostic methods |
| 01/27/1998 | US5712097 Tumor suppressor gene, DPC4 |
| 01/27/1998 | US5712093 RXR homodimer formation |
| 01/27/1998 | US5711968 Composition and method for the controlled release of metal cation-stabilized interferon |
| 01/27/1998 | US5711957 Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable implant |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/27/1998 | US5711881 Hematopoietic inhibiting factor containing compositions |
| 01/27/1998 | US5711853 Pulp from newsprint or eucalyptus fibers |
| 01/26/1998 | CA2203745A1 Pro-protein converting enzyme |
| 01/25/1998 | CA2207071A1 Aprotinin variants having improved properties |
| 01/22/1998 | WO1998002583A1 Novel catalytic rna molecules |
| 01/22/1998 | WO1998002558A2 Chimeric receptors for jak-stat signal transduction |
| 01/22/1998 | WO1998002555A1 Applications for regulatory region of nos isoforms |
| 01/22/1998 | WO1998002554A2 Cytochrome p450 expression in enterobacteria |
| 01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | WO1998002546A2 Dna immunization against chlamydia infection |
| 01/22/1998 | WO1998002543A1 Novel vegf-like factors |
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002540A1 Chimeric heteromultimer adhesins |
| 01/22/1998 | WO1998002538A1 Melanoma associated peptide analogues and vaccines against melanoma |
| 01/22/1998 | WO1998002525A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002462A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 01/22/1998 | WO1998002461A2 Liquid phase peptide syntheses of kl-4 pulmonary surfactant |
| 01/22/1998 | WO1998002460A1 Selective acylation method |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002458A1 Differentiation inhibitor |
| 01/22/1998 | WO1998002456A2 Human c-type lectin |
| 01/22/1998 | WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | WO1998002453A2 Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
| 01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | WO1998002240A1 Preservation by foam formation |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002188A1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 01/22/1998 | WO1998002178A1 Methods of controlling axonal growth |
| 01/22/1998 | WO1998002177A1 Wound healing accelerators |
| 01/22/1998 | WO1998002175A1 Remedies/preventives for viral infections, process for preparing the same, and method for preventing/treating viral infections |
| 01/22/1998 | WO1998002173A1 Method for treatment of systemic sclerosis and related fibrotic diseases |
| 01/22/1998 | WO1998002165A1 Appetite suppression |
| 01/22/1998 | WO1998002150A1 System for genetically treating cardiac conduction disturbances |
| 01/22/1998 | WO1998002148A2 Pharmaceutical composition |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1998002142A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/22/1998 | WO1998002134A1 Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor |
| 01/22/1998 | WO1998002133A1 Compositions and methods for the treatment of male-pattern baldness |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | DE19702835A1 New nucleic acid encoding protein that increases neuronal cell proliferation |
| 01/22/1998 | CA2547967A1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 01/22/1998 | CA2295500A1 Methods of controlling axonal growth |
| 01/22/1998 | CA2267620A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 01/22/1998 | CA2261023A1 Novel catalytic rna molecules |
| 01/22/1998 | CA2260967A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/22/1998 | CA2260966A1 Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor |
| 01/22/1998 | CA2260892A1 Appetite suppression |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2260258A1 Wound healing accelerators |
| 01/22/1998 | CA2260233A1 A scalable method of preserving biologically active materials by desiccation |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2259136A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | CA2258721A1 Chimeric heteromultimer adhesins |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/21/1998 | EP0819763A1 Engineered acarid allergen and process for producing the same |
| 01/21/1998 | EP0819760A1 Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
| 01/21/1998 | EP0819758A2 Cationic vehicle: DNA complexes and their use in gene therapy |
| 01/21/1998 | EP0819757A2 Enzyme which activates an interferon-gamma inducing polypeptide |
| 01/21/1998 | EP0819700A1 Extraction of myelin basic protein |
| 01/21/1998 | EP0819699A1 A process for producing a glycosylated amino compound |
| 01/21/1998 | EP0819171A1 Antibodies for the detection of hla-g |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0819137A1 Peptides with growth promotion properties |
| 01/21/1998 | EP0819136A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/21/1998 | EP0819135A1 Sugar-modified cytostatics |
| 01/21/1998 | EP0819010A1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution |
| 01/21/1998 | EP0819009A1 Ovulation triggering drugs |
| 01/21/1998 | EP0819008A1 Method of using lectins for prevention and treatment of skin diseases and disorders |
| 01/21/1998 | EP0819005A1 2-acylaminopropanamides as tachykinin receptor antagonists |
| 01/21/1998 | EP0819003A1 A method for the treatment of macular degeneration |
| 01/21/1998 | EP0818996A1 Controlled release biodegradable micro- and nanospheres containing cyclosporin |
| 01/21/1998 | EP0804609A4 NOVEL p53 RESPONSE GENES |
| 01/21/1998 | EP0527806B1 Epithelins: novel cysteine - rich growth modulating proteins |
| 01/21/1998 | EP0504363B1 PURIFIED IgG ANTIBODIES |
| 01/21/1998 | CN1171133A Gene participating in apoptosis |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171118A Fibronectin adhesion inhibitors |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171116A N-substituted glycine derivatives as inhibotors of factor Xa |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
| 01/21/1998 | CN1171049A Powder formulations containing melezitose as diluent |
| 01/21/1998 | CN1171046A Aerosol formulations of peptides and proteins |
| 01/21/1998 | CN1170756A Strawberry wine and its producing method |
| 01/21/1998 | CN1170590A Medicine for curing crawl disease of bee |